{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:09:23Z","timestamp":1792008563200,"version":"4.4.0"},"reference-count":56,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1001\/jamapsychiatry.2020.1214","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T17:00:47Z","timestamp":1591203647000},"page":"1012","source":"Crossref","is-referenced-by-count":83,"title":["Effect of Aspirin vs Placebo on the Prevention of Depression in Older People"],"prefix":"10.1001","volume":"77","author":[{"given":"Michael","family":"Berk","sequence":"first","affiliation":[{"name":"The Institute for Mental and Physical Health and Clinical Translation Strategy Research Centre, Deakin University School of Medicine, Geelong, Australia"},{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia"},{"name":"Department of Psychiatry, University of Melbourne, Parkville, Australia"},{"name":"Orygen Youth Health Research Centre, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn L.","family":"Woods","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj C.","family":"Shah","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Department of Family Medicine, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Reid","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia"},{"name":"School of Public Health, Curtin University, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsdon","family":"Storey","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharyn","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Lockery","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Wolfe","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Mohebbi","sequence":"additional","affiliation":[{"name":"The Institute for Mental and Physical Health and Clinical Translation Strategy Research Centre, Deakin University School of Medicine, Geelong, Australia"},{"name":"Biostatistics Unit, Faculty of Health, Deakin University, Geelong, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seetal","family":"Dodd","sequence":"additional","affiliation":[{"name":"The Institute for Mental and Physical Health and Clinical Translation Strategy Research Centre, Deakin University School of Medicine, Geelong, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Murray","sequence":"additional","affiliation":[{"name":"Berman Center for Outcomes and Clinical Research, Hennepin Healthcare Research Institute, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Stocks","sequence":"additional","affiliation":[{"name":"Discipline of General Practice, Adelaide Medical School, University of Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"Epworth Centre for Innovation in Mental Health, the Epworth Clinic, Epworth Healthcare, Camberwell, Australia"},{"name":"Monash Alfred Psychiatry Research Centre, Central Clinical School, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Mazza","sequence":"additional","affiliation":[{"name":"The Institute for Mental and Physical Health and Clinical Translation Strategy Research Centre, Deakin University School of Medicine, Geelong, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Agustini","sequence":"additional","affiliation":[{"name":"The Institute for Mental and Physical Health and Clinical Translation Strategy Research Centre, Deakin University School of Medicine, Geelong, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"McNeil","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"yoi200029r1","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1176\/appi.ajp.2008.07091422","article-title":"Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions.","volume":"165","author":"Cuijpers","year":"2008","journal-title":"Am J Psychiatry"},{"key":"yoi200029r2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1\u00df, tumour necrosis factor a and C-reactive protein in patients with major depressive disorder.","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain Behav Immun"},{"issue":"3","key":"yoi200029r3","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","article-title":"CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.","volume":"150","author":"Valkanova","year":"2013","journal-title":"J Affect Disord"},{"issue":"Pt C","key":"yoi200029r4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.pnpbp.2017.04.026","article-title":"Effect of antidepressant treatment on peripheral inflammation markers: a meta-analysis.","volume":"80","author":"Wiedlocha","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"yoi200029r5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1192\/bjp.bp.109.076430","article-title":"Association of high-sensitivity C-reactive protein with de novo major depression.","volume":"197","author":"Pasco","year":"2010","journal-title":"Br J Psychiatry"},{"issue":"1","key":"yoi200029r6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1741-7015-11-74","article-title":"Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness.","volume":"11","author":"Berk","year":"2013","journal-title":"BMC Med"},{"issue":"10","key":"yoi200029r7","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1017\/S104161021600079X","article-title":"ASPREE-D: Aspirin for the prevention of depression in the elderly.","volume":"28","author":"Berk","year":"2016","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"yoi200029r8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1747493017741383","article-title":"The aspirin in reducing events in the elderly trial: statistical analysis plan.","volume":"13","author":"Wolfe","year":"2018","journal-title":"Int J Stroke"},{"issue":"2","key":"yoi200029r9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cct.2013.09.014","article-title":"Study design of Aspirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.","volume":"36","author":"ASPREE Investigator Group","year":"2013","journal-title":"Contemp Clin Trials"},{"issue":"20","key":"yoi200029r12","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"yoi200029r14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials.","volume":"158","author":"Chan","year":"2013","journal-title":"Ann Intern Med"},{"issue":"1","key":"yoi200029r15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00784-002-0188-x","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.","volume":"7","author":"Moher","year":"2003","journal-title":"Clin Oral Investig"},{"issue":"9609","key":"yoi200029r16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(07)61835-2","article-title":"CONSORT for reporting randomised trials in journal and conference abstracts.","volume":"371","author":"Hopewell","year":"2008","journal-title":"Lancet"},{"key":"yoi200029r17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eurpsy.2018.05.006","article-title":"Patient centric measures for a patient centric era: agreement and convergent between ratings on the Patient Global Impression of Improvement (PGI-I) scale and the Clinical Global Impressions-Improvement (CGI-S) scale in bipolar and major depressive disorder.","volume":"53","author":"Mohebbi","year":"2018","journal-title":"Eur Psychiatry"},{"issue":"5","key":"yoi200029r18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155431","article-title":"Screening for depression in the general population with the Center for Epidemiologic Studies Depression (CES-D): a systematic review with meta-analysis.","volume":"11","author":"Vilagut","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"yoi200029r19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0749-3797(18)30622-6","article-title":"Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale).","volume":"10","author":"Andresen","year":"1994","journal-title":"Am J Prev Med"},{"issue":"15","key":"yoi200029r20","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/archinte.159.15.1701","article-title":"Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D).","volume":"159","author":"Irwin","year":"1999","journal-title":"Arch Intern Med"},{"issue":"4","key":"yoi200029r21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/002076400004600402","article-title":"The performance of the Center for Epidemiologic Study Depression Scale (CES-D) in an Arab female community.","volume":"46","author":"Ghubash","year":"2000","journal-title":"Int J Soc Psychiatry"},{"issue":"1","key":"yoi200029r23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis.","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA"},{"issue":"11","key":"yoi200029r24","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/gerona\/glw342","article-title":"Baseline characteristics of participants in the ASPREE (Aspirin in Reducing Events in the Elderly) study.","volume":"72","author":"McNeil","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"16","key":"yoi200029r25","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly.","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"issue":"16","key":"yoi200029r26","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","article-title":"Effect of aspirin on disability-free survival in the healthy elderly.","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"issue":"16","key":"yoi200029r27","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly.","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"yoi200029r28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00004850-200607000-00004","article-title":"Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression.","volume":"21","author":"Brunello","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"yoi200029r29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jad.2018.04.063","article-title":"Neither all anti-inflammatory drugs nor all doses are effective in accelerating the antidepressant-like effect of fluoxetine in an animal model of depression.","volume":"235","author":"Alboni","year":"2018","journal-title":"J Affect Disord"},{"issue":"2","key":"yoi200029r30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neulet.2011.05.035","article-title":"Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats.","volume":"499","author":"Wang","year":"2011","journal-title":"Neurosci Lett"},{"issue":"11","key":"yoi200029r31","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.19082\/5770","article-title":"The effects of combined sertraline and aspirin therapy on depression severity among patients with major depressive disorder: a randomized clinical trial.","volume":"9","author":"Sepehrmanesh","year":"2017","journal-title":"Electron Physician"},{"issue":"5","key":"yoi200029r32","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1532-5415.2010.02827.x","article-title":"Aspirin use, depression, and cognitive impairment in later life: the Health in Men study.","volume":"58","author":"Almeida","year":"2010","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"yoi200029r33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000319530","article-title":"Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression.","volume":"79","author":"Pasco","year":"2010","journal-title":"Psychother Psychosom"},{"issue":"1","key":"yoi200029r34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/acps.12957","article-title":"New drug candidates for depressiona nationwide population-based study.","volume":"139","author":"Kessing","year":"2019","journal-title":"Acta Psychiatr Scand"},{"key":"yoi200029r35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fpsyt.2019.00375","article-title":"COX-2 inhibitors, aspirin, and other potential anti-inflammatory treatments for psychiatric disorders.","volume":"10","author":"M\u00fcller","year":"2019","journal-title":"Front Psychiatry"},{"issue":"4","key":"yoi200029r36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00004850-200607000-00005","article-title":"Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study.","volume":"21","author":"Mendlewicz","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"yoi200029r37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pnpbp.2013.09.006","article-title":"Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis.","volume":"48","author":"Na","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"12","key":"yoi200029r38","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/1440-1681.12660","article-title":"Beneficial effect of aspirin against interferon-a-2b-induced depressive behavior in Sprague Dawley rats.","volume":"43","author":"Bhatt","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"yoi200029r39","article-title":"Statin and aspirin use and the risk of mood disorders among men.","volume":"19","author":"Williams","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"key":"yoi200029r40","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.79","article-title":"Aspirin decreases the risk of depression in older men with high plasma homocysteine.","volume":"2","author":"Almeida","year":"2012","journal-title":"Transl Psychiatry"},{"key":"yoi200029r41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jad.2019.01.020","article-title":"Use of non-steroidal anti-inflammatory drugs, aspirin and the risk of depression: the \u201cSeguimiento Universidad de Navarra (SUN)\u201d cohort.","volume":"247","author":"Molero","year":"2019","journal-title":"J Affect Disord"},{"key":"yoi200029r42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jad.2015.03.044","article-title":"Aspirin and statin use and the subsequent development of depression in men and women: results from a longitudinal population-based study.","volume":"182","author":"Glaus","year":"2015","journal-title":"J Affect Disord"},{"issue":"1","key":"yoi200029r43","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12200","article-title":"A double-blind, randomized, placebo-controlled study of aspirin and N-acetylcysteine as adjunctive treatments for bipolar depression.","volume":"80","author":"Bauer","year":"2018","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"yoi200029r44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-017-0073-7","article-title":"Treatment of bipolar depression with minocycline and\/or aspirin: an adaptive, 2\u00d72 double-blind, randomized, placebo-controlled, phase IIA clinical trial.","volume":"8","author":"Savitz","year":"2018","journal-title":"Transl Psychiatry"},{"issue":"24","key":"yoi200029r45","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1136\/heartjnl-2016-309573","article-title":"Trends in the epidemiology of cardiovascular disease in the UK.","volume":"102","author":"Bhatnagar","year":"2016","journal-title":"Heart"},{"issue":"1","key":"yoi200029r46","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/wps.20388","article-title":"Has increased provision of treatment reduced the prevalence of common mental disorders? review of the evidence from four countries.","volume":"16","author":"Jorm","year":"2017","journal-title":"World Psychiatry"},{"key":"yoi200029r47","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.neubiorev.2019.09.025","article-title":"Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders.","volume":"107","author":"Morris","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"yoi200029r48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12888-015-0394-0","article-title":"A shared framework for the common mental disorders and non-communicable disease: key considerations for disease prevention and control.","volume":"15","author":"O\u2019Neil","year":"2015","journal-title":"BMC Psychiatry"},{"issue":"2","key":"yoi200029r49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10555-017-9675-z","article-title":"Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.","volume":"36","author":"Ornelas","year":"2017","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"yoi200029r50","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s11136-018-2040-z","article-title":"Quality of Life for 19,114 participants in the ASPREE (Aspirin in Reducing Events in the Elderly) study and their association with sociodemographic and modifiable lifestyle risk factors.","volume":"28","author":"Stocks","year":"2019","journal-title":"Qual Life Res"},{"issue":"8","key":"yoi200029r51","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","article-title":"Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin.","volume":"100","author":"Ikonomidis","year":"1999","journal-title":"Circulation"},{"issue":"11","key":"yoi200029r52","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1211\/jpp.61.11.0010","article-title":"Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome.","volume":"61","author":"Gao","year":"2009","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"yoi200029r53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00029330-200601010-00006","article-title":"Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.","volume":"119","author":"Chen","year":"2006","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"yoi200029r54","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.09m05117yel","article-title":"Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial.","volume":"71","author":"Laan","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"10152","key":"yoi200029r55","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"key":"yoi200029r56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ahj.2017.12.006","article-title":"ASCEND: a Study of Cardiovascular Events in Diabetes: characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes.","volume":"198","author":"Bowman","year":"2018","journal-title":"Am Heart J"},{"key":"yoi200029r10","volume-title":"National Statement on Ethical Conduct in Human Research (2007)\u2014Updated 2015","author":"National Health and Medical Research Council","year":"2015"},{"key":"yoi200029r11","volume-title":"The Australian Code for the Responsible Conduct of Research","author":"National Health and Medical Research Council","year":"2018"},{"key":"yoi200029r22","author":"World Health Organization","year":"2017"},{"key":"yoi200029r13","unstructured":"US Food and Drug Administration. Integrated addendum to ICH E6(R1): Guideline for good clinical practice E6(R2); International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Published 2016. Accessed April 20, 2020. https:\/\/www.fda.gov\/files\/drugs\/published\/E6%28R2%29-Good-Clinical-Practice--Integrated-Addendum-to-ICH-E6%28R1%29.pdf"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2766709\/jamapsychiatry_berk_2020_oi_200029_1601309843.49394.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T15:16:02Z","timestamp":1602083762000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2766709"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.1214","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}